Knee infection trial: drug levels after spacer surgery
Part of Infections clinical trials.
This trial studies how antibiotics reach the knee joint after a temporary antibiotic spacer is placed. It may help improve treatment for people having two-stage surgery for a knee prosthesis infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a knee joint infection around a previously placed artificial knee (prosthesis).
- You are scheduled for a two-stage replacement surgery.
- Your orthopedic and anesthesia doctors have approved the surgery.
- You are 18 years or older.
- You are willing and able to give written consent after understanding the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to measure how well antibiotics reach the infected area around a hip implant during a two-stage replacement surgery. If you are already planning this surgery, researchers want to see if the levels of antibiotics in the spacer are high enough to fight the infection.
This trial compares two types of antibiotic spacers for people with a long-term knee replacement infection. It tests whether a spacer made entirely of antibiotic cement or one with a metal core works better to treat the infection before a new knee replacement.
This study looks at how antibiotic treatment (especially the course length and approach) relates to infection control and results after a two-step surgery for joint infections. If you’ve had a spacer placed, finished at least 6 weeks of antibiotics, and then had the second surgery, the research team may want to follow your outcomes over time.
This trial tests a new type of temporary spacer for infected hip, knee, or shoulder replacements. The spacer is made of a special material that releases antibiotics to fight the infection before a new joint can be placed.
This trial tests a new antibiotic, TNP-2092, given as a shot directly into the knee joint for people with a persistent infection after knee replacement. It is for those whose infection is caused by certain bacteria and who are willing to stay in the hospital for 2 weeks.
This trial tests whether putting antibiotics directly inside the bone during surgery can improve outcomes for an infected knee prosthesis when the implant is being kept. It may help more people avoid needing full implant removal and replacement.
Hear when a new Periprosthetic Knee Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.